132 related articles for article (PubMed ID: 35101541)
1. Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to regulate TXNIP expression.
Cheng Z; Lu C; Wang H; Wang N; Cui S; Yu C; Wang C; Zuo Q; Wang S; Lv Y; Yao M; Jiang L; Qin W
Cancer Lett; 2022 Apr; 531():1-13. PubMed ID: 35101541
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA HOXA-AS2 promotes cell migration and invasion via upregulating IGF-2 in non-small cell lung cancer as an oncogene.
Zheng FX; Wang XQ; Zheng WX; Zhao J
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4793-4799. PubMed ID: 31210310
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
4. HOXC-AS2 mediates the proliferation, apoptosis, and migration of non-small cell lung cancer by combining with HOXC13 gene.
Liu B; Li J; Li JM; Liu GY; Wang YS
Cell Cycle; 2021 Jan; 20(2):236-246. PubMed ID: 33427025
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.
Yang K; Zhang W; Zhong L; Xiao Y; Sahoo S; Fassan M; Zeng K; Magee P; Garofalo M; Shi L
Cell Death Differ; 2023 Jun; 30(6):1533-1549. PubMed ID: 37041291
[TBL] [Abstract][Full Text] [Related]
6. Identification of LHFPL3-AS2 as a prognostic biomarker in lung adenocarcinoma.
Zhou X; Liu G; Lin M; Li L; Cao D
Indian J Pathol Microbiol; 2022; 65(2):288-295. PubMed ID: 35435361
[TBL] [Abstract][Full Text] [Related]
7. LncRNA GAS6-AS2 promotes non-small-cell lung cancer cell proliferation via regulating miR-144-3p/ MAPK6 axis.
Hou G; Yang J; Tang J; He Y
Cell Cycle; 2021 Jan; 20(2):179-193. PubMed ID: 33459113
[TBL] [Abstract][Full Text] [Related]
8. Reduced LHFPL3-AS2 lncRNA expression is linked to altered epithelial polarity and proliferation, and to ileal ulceration in Crohn disease.
Sosnovski KE; Braun T; Amir A; BenShoshan M; Abbas-Egbariya H; Ben-Yishay R; Anafi L; Avivi C; Barshack I; Denson LA; Haberman Y
Sci Rep; 2023 Nov; 13(1):20513. PubMed ID: 37993670
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA EPB41L4A-AS2 inhibited non-small cell lung cancer proliferation, invasion and promoted cell apoptosis.
Shu J; Li S; Chen YB; Zhu QF; Yu XH
Neoplasma; 2018 Sep; 65(5):664-672. PubMed ID: 30249102
[TBL] [Abstract][Full Text] [Related]
11. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
[TBL] [Abstract][Full Text] [Related]
12. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA SLNCR1 regulates non‑small cell lung cancer migration, invasion and stemness through interactions with secretory phospholipase A2.
Xu W; Xu Q; Kuang D; Wang Z; Lu Q; Lin Q; Wu H; Chen L
Mol Med Rep; 2019 Sep; 20(3):2591-2596. PubMed ID: 31524254
[TBL] [Abstract][Full Text] [Related]
14. CTBP1-AS2 promoted non-small cell lung cancer progression via sponging the miR-623/MMP3 axis.
Yang G; Zhang C
Environ Sci Pollut Res Int; 2022 May; 29(25):38385-38394. PubMed ID: 35076836
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
16. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC.
Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C
Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population.
Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Elsayed RS; Sherif MM; Abbas A; El Shabrawy M
J Gene Med; 2021 Dec; 23(12):e3381. PubMed ID: 34312940
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
20. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
